company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-162672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-162672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7164000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25503000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-55554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-185559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-185559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-87422000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,174006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,80177000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,80177000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,318668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,318668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,318668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,213084000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6828000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-171297000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-171297000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7745000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,41040000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-118065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-118065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4586000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-250715000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,171451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,193000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83657000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83657000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11081000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2609000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-193250000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-149565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-149565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,99550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4753000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124052000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,171783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-453000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,42525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,42525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,122217000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8376000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,130593000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,130593000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1299000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,150184000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3420000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-165271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-165271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7584000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22256000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-64262000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-196462000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-196462000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3110000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,184274000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-380000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,138762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,138762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7664000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7642000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7642000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-53000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-50111000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-200006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-200006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7912000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3339000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,53768000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-108887000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-108887000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9686000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-279230000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,333867000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4303000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,22000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,22000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9473000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9517000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9473000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-173000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-58939000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-208957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-208957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6758000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30855000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3903000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-163990000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-163990000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10830000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-453278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,461650000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,44000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391645000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,398451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,398495000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,232293000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-180392000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-180392000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8205000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3568000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32034000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-166103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-166103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14428000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-460189000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,305015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-93000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-169695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-169695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-353000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-326704000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-176096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-176096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8858000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6605000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,34958000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-60953000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-186628000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-186628000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,536362000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-564000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,405952000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,405952000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-50000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33643000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-16357000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-16357000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,372000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,203339000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-199318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-199318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8709000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2582000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,36803000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-64971000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-216195000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-216195000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10431000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10113000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,253144000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,190000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,172790000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,172790000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,55030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,34000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11659000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6812000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,228452000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,228452000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7750000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2669000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,145554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-341530000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,42895000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42895000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9985000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-115980000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,147611000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-200000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21446000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21446000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20069000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20069000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20069000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-60000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,84350000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,188141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,188141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9724000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6553000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,267789000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,503663000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,503663000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-470456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91618000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,391000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-387776000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-387776000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-105000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16120000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-94100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-182980000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-182980000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-132000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-67225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,87876000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,87876000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8560000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29771000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-123291000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2916000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2916000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6155000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-409318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,183987000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-216000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-231702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-231702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,21298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,227000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-136000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-207397000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34468000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34468000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8665000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,111681000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,32527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,118405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,118405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-372432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,318201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-269000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-70043000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-70043000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,136705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,987000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,137692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,137692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,84000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,186138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26467000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26467000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8593000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29866000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,93969000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,105961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,105961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-550369000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,439126000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1411000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-131228000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-131228000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8680000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16947000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-117000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-58000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17175000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78076000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78076000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12373000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,84624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21638000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,40559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28046000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-391815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,426613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,404000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7156000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7156000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12808000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16771000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,874000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4837000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4837000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-31000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,52521000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-312627000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-312627000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10691000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,445632000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-209474000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-65778000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65778000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16607000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-458971000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,437510000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,472000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37596000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37596000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-27805000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,21670000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-799000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110308000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,243000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1541000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61712000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61712000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,58288000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8057000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1801000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-439735000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,405091000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,31754000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4691000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4691000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28714000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,186202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,157488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,157488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,152148000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1541000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-232457000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-232457000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15788000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,46407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-175762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-175762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15526000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-380949000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,376544000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-476000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17768000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60134000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,499000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-145254000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,15970000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,140000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-159382000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-159382000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42639000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25349000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-127920000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-127920000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11701000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-323028000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,424662000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-51000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,89882000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,89882000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24408000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57813000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,33405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,33405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3487000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,15963000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,658000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-170060000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-170060000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47099000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18353000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-87647000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-87647000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-362795000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,402194000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,444000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30545000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30545000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20477000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,294383000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,83327000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,357233000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,357233000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2126000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,298005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-29116000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-180846000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-180846000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16336000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,40926000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-58199000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-181783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-181783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14676000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-357400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,356176000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7889000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18011000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18011000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,41210000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-8190000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,73341000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,108185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,108185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-93304000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,66146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,412000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-198704000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-198704000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16363000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,58013000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-97908000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-222236000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-222236000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10558000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125655000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,371423000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-21172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,214038000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,214038000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4588000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13386000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41616000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2596000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39620000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,21538000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,60000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-220992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-220992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,68677000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,27984000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-110266000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-110266000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13420000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,372579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-716000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,278443000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,278443000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10037000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,46234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,36197000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,36197000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1290000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,205664000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,21347000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-93816000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-93816000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16168000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,56813000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-41238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-62073000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-62073000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8797000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-166480000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1074000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-100935000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-100935000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2171000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,51839000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,49668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,49668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-953000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-114293000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,21346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2283000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74669000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74669000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15747000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,59570000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28495000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,29143000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29143000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-340906000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,259710000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-28967000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-122690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-122690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3158000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10276000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45903000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-381000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52640000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52640000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-575000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-41482000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,21382000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3067000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16415000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,51637000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-47087000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15137000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15137000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11974000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-224624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,133810000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,80000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-102708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-102708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4144000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8846000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2620000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110523000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,20603000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,581000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36151000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36151000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14963000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,69213000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7165000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,40860000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40860000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15918000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-245453000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,206903000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3314000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57782000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57782000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3603000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24856000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21253000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21253000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2710000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1621000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,20722000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39537000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39537000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14569000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,56869000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33755000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,65656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,65656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13883000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-169623000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,215156000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34791000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34791000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5583000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17463000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-175000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,113826000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,23337000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,380000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,27759000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27759000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,142460000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-40946000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,144724000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,144724000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14788000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,23075000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,201693000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33043000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,176937000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,176937000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-82370000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,84143000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,74924000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,93762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,93762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4401000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,411022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,18994000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4196000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,249548000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,249548000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,70020000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-68726000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,265692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,265692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11099000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-248273000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,98393000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-160979000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-160979000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-304820000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11249000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-289565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-289565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-183464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,17527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1164000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,31169000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31169000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14890000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,79105000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,56489000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,181653000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,181653000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17378000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-129394000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70489000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-76283000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-76283000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6055000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,136638000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1450000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,132033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,132033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,2112000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,239515000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,17476000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1054000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-291267000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-291267000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,568146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-122018000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,170086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,170086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27960000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-160000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-115588000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78267000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-225281000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-225281000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3313000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,150318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,152705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,152705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1501000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,99011000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,16987000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1936000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,102185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,102185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,82388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26506000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,227511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,227511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42984000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100928000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,122065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20786000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20786000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,14188000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-4700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,46635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17108000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,73231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,73231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,801000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,280757000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,16706000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2260000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,227301000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,227301000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16343000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30940000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,252657000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,252657000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60153000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94365000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4933000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4933000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10331000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9566000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,88403000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,78956000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,78956000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,338202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,16825000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1897000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,206250000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,206250000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18059000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2802000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,100196000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,321703000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,321703000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29612000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-163349000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76663000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-116298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-116298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3879000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-105033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,56434000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1270000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-51208000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-51208000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-5857000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,148340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,16619000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,128456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,128456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19192000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,153539000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80161000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,381348000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,381348000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20912000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-166355000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,137378000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49889000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49889000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11448000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-92005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3417000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,100917000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1198000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2079000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2079000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-555000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,332983000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,16573000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3247000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1525096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1525096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18826000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,203391000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1432735000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,314578000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,314578000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15721000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,123170000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-98396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40904000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40904000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,25264000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-143005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-12983000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43539000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-13861000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-101046000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-101046000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-1426000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,171202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,16441000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,268631000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,268631000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27140000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47809000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18796000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,324784000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,324784000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18041000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-128215000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107118000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-94007000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,63620000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11602000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-41989000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-41989000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-378000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,243279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,13148000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1835000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,267427000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,267427000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27698000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,41597000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,127027000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,463749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,463749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16358000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-155421000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,121589000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50190000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50190000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-61842000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,50472000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2647000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-13015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-430000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,400114000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9067000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,57518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25847000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,106606000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,144818000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,334789000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,334789000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24291000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-245824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125322000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,146438000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-248999000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-248999000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1132000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-104000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30538000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-8946000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-3201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,102945000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,14595000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11936000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,583234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,583234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26256000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-16178000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-147304000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,446008000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,446008000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-908388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-128238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,195715000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-39319000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-896991000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-896991000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-819000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-36062000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,198614000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,161421000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,161421000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,5652000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-283910000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,13850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1892000.0
